Related Experiment Video
Updated: Aug 5, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
HIV/AIDS: a minority health issue
Victoria A Cargill1, Valerie E Stone
1Office of AIDS Research, National Institutes of Health, 2 Center Drive, Room 4E20, Bethesda, MD 20892-0255, USA. vc52x@nih.gov
Racial and ethnic minorities face significant HIV challenges due to social determinants and healthcare disparities. Improving care and increasing minority participation in clinical trials are crucial for better health outcomes.
Area of Science:
- Public Health
- Health Disparities
- Infectious Diseases
Background:
- HIV disproportionately affects racial and ethnic minorities, exacerbating existing social and economic challenges.
- Women within these minority populations are particularly vulnerable to HIV infection.
- Unequal access to and treatment within healthcare systems complicate HIV care for minorities.
Purpose of the Study:
- To highlight the multifaceted challenges in managing HIV among racial and ethnic minorities.
- To address the critical underrepresentation of minorities in HIV clinical trials.
- To emphasize the importance of culturally competent care and patient-provider relationships.
Main Methods:
- Review of existing literature on HIV disparities and healthcare access for minority populations.
- Analysis of factors contributing to poor participation in HIV clinical trials.
- Discussion of strategies for improving HIV prevention and care within clinical settings.
Main Results:
- Minority patients experience barriers including insurance status, provider-patient race concordance, and satisfaction impacting outcomes.
- Comorbid conditions like depression and substance abuse significantly affect treatment adherence.
- Minority underrepresentation in clinical trials stems from provider bias, mistrust, and systemic issues.
Conclusions:
- Strengthening the patient-provider therapeutic alliance is vital for treatment adherence.
- Addressing barriers and fostering community-academic partnerships are essential for increasing clinical trial participation.
- Integrating HIV prevention into routine care is critical, despite provider challenges.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Amebiasis

